Preprint · CC0
via OpenAlex
Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study
Gina LaRocca, Thor Aspelund, Anders Møller Greve, Guðný Eiríksdóttir, Tushar Acharya, Guðmundur Þorgeirsson, Tamara B. Harris, Lenore J. Launer, Vilmundur G. Gudnason, Andrew E Arai
European Heart Journal · 2017 · ▲ 29 citations
Abstract
BACKGROUND: Fibrosis is a key pathological process in many chronic inflammatory disease states. AIMS: We hypothesized that tissue inhibitor metalloproteinase-1 and matrix metalloproteinase-9 (TIMP-1 and MMP-9), biomarkers of fibrosis, would predict all-cause mortality and we assessed the incremental value of these biomarkers when adjusting for clinical and other biomarkers. METHODS: The cohort included 5511 community-dwelling participants in the AGES-Reykjavik Study. The baseline Cox proportional hazards regression model was based on the Framingham Risk Score variables; we added TIMP-1, MMP-9, serum high-sensitivity C-reactive protein (hsCRP), and estimated glomerular filtration rate (eGFR). The primary outcome was all-cause 10-year mortality. Cause of death was categorized as cardiovascular death (CVD), cancer death, and other causes. RESULTS: Participants averaged 76 years and 43% were male. Ten-year mortality was 41% (2263 deaths). Of these, 915 (16.6%) died of cardiovascular disease (CVD), 543 (9.9%) with cancer, and 805 (14.6%) from other causes. For 10-year mortality, age was the strongest predictor (log likelihood χ2 = 798.7, P < 0.0001), followed by TIMP-1 (χ2 = 125.2, P < 0.0001), female gender, current smoker, diabetes mellitus, total cholesterol, eGFR (χ2 16.7, P < 0.0001), body mass index, and hsCRP (χ2 11.3, P = 0.0008) in that order. TIMP-1 and hsCRP had the highest continuous net reclassification improvement over the baseline model for 5-year survival [net reclassification index (NRI) 0.28 and 0.19, respectively, both P < 0.0001] and for 10-year survival (NRI 0.19 and 0.11, respectively, both statistically significant). CONCLUSION: TIMP-1 is the strongest predictor of all-cause mortality after age. The metabolic pathways regulating extracellular matrix homeostasis and fibrogenic processes appear pathologically relevant and are prognostically important.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/eurheartj/ehx510
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
LaRocca, G., Aspelund, T., Greve, A.M., Eiríksdóttir, G., Acharya, T., Þorgeirsson, G., Harris, T.B., Launer, L.J., Gudnason, V.G., & Arai, A.E. (2017). Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study. <em>European Heart Journal</em>. https://doi.org/10.1093/eurheartj/ehx510
Vancouver
LaRocca G, Aspelund T, Greve AM, Eiríksdóttir G, Acharya T, Þorgeirsson G, et al. Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study. European Heart Journal. 2017. doi:10.1093/eurheartj/ehx510.
BibTeX
@unpublished{gina2017Fibros,
title = {Fibrosis as measured by the biomarker, tissue inhibitor metalloproteinase-1, predicts mortality in Age Gene Environment Susceptibility-Reykjavik (AGES-Reykjavik) Study},
author = {Gina LaRocca and Thor Aspelund and Anders Møller Greve and Guðný Eiríksdóttir and Tushar Acharya and Guðmundur Þorgeirsson and Tamara B. Harris and Lenore J. Launer and Vilmundur G. Gudnason and Andrew E Arai},
journal = {European Heart Journal},
year = {2017},
doi = {10.1093/eurheartj/ehx510},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European Heart Journal 2023
Open access · OA
Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction
BMC Medicine 2019
Open access · CC-BY
The frailty index is a predictor of cause-specific mortality independent of familial effects from midlife onwards: a large cohort study
Circulation 2005
Citation only
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
Cancer Medicine 2021
Open access · CC-BY
Prevalence of frailty and prediction of mortality in Chinese cancer patients using a frailty index‐based clinical algorithm—A multicentre study
GeroScience 2025
Open access · CC-BY
Epigenetic age acceleration and mortality risk prediction in US adults
International Journal of Cancer 2021
Citation only